. Population pharmacokinetic-pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease. CPT Pharmacometrics Syst Pharmacol. 2022 Dec;11(12):1578-1591. Epub 2022 Sep 27 PubMed.


Please login to recommend the paper.


No Available Comments

Make a Comment

To make a comment you must login or register.